Abstract
To investigate the effect of boosting immunity via mucosal route vis-a-vis parenteral route in the mouse model of haemorrhagic septicaemia, mice preimmunized with OMP of Pasteurella multocida (B:2) were immunized with 102 cfu of P. multocida via intranasal and subcutaneous routes. Mice were challenged through intranasal route (natural route of infection) with 108 cfu 14 days after immunization. Group of mice which were immunized intranasally showed significant protection (P < 0.05) of 88% as compared to 50% protection in group of mice immunized subcutaneously. In the control group of mice, 100% mortality occurred within 48 h. of challenge. The results of present study indicated that boosting of immunity via mucosal route in mice preimmunized with OMP provided better protection against P. multocida. This study may have implications for developing better vaccination strategies for the natural host.
References
Bain RVS (1955) Studies on haemorrhagic septicaemia of cattle. IV. A preliminary examination of antigens of Pasteurella multocida type I. Br Vet J 3:492–498
Benkirane A, De Alwis MCL (2002) Haemorrhagic septicaemia, its significance, prevention and control in Asia. Vet Med-Czech 47:234–240
Choi-Kim K, Maheswaran SK, Felice LJ, Mlolitor TW (1991) Relationship between the iron regulated outer membrane proteins and the outer membrane proteins of in vivo grown Pasteurella multocida. Vet Microbiol 28:75–92
Harper M, Boyce JD, Adler B (2006) Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiol Lett 265:1–10
Hodgson JC, Finucane A, Dagleish MP, Ataei S, Parton R, Coote JG (2005) Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration. Infect Immun 73:1475–1481
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein estimation with the folin-phenol reagent. J Biol Chem 193:265–275
Myint A, Jones TO, Nyunt HH (2005) Safety, efficacy and cross-protectivity of a live intranasal aerosol haemorrhagic septicaemia vaccine. Vet Rec 156:41–45
Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148–158
Vegad JL, Katiyar AK (2001) Textbook of veterinary special pathology. Country Press, London, pp 307–312
Vordermeier HM, Huygen K, Singh M, Hewinson RG, Xing Z (2006) Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG. Infect Immun 74:1416–1418
Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zaganiacz A, Hitt M, Xing Z (2004) Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 173:6357–6365
Acknowledgments
Authors like to thank Dr. B. R. Gulati of the National Research Centre for Equines, Hisar for providing the ultracentrifuge facility.
Conflict of interest
Authors of this manuscript do not have any financial or personal relationship that could inappropriately bias the content of the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kharb, S., Charan, S. Mucosal immunization provides better protection than subcutaneous immunization against Pasteurella multocida (B:2) in mice preimmunized with the outer membrane proteins. Vet Res Commun 35, 457–461 (2011). https://doi.org/10.1007/s11259-011-9484-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-011-9484-8